15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Meritage Corporation, 4 rate it Buy or better, 5 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $58.00 to $93.00, a moderate spread. The average target of $78.25 sits 21% above the current $64.41. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.57 next quarter toward $6.10 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Moderate Buy
Strong Buy00%
Buy444%
Hold556%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to Meritage Corporation.
As of Sep, 4 of 9 firms rate MTH a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MTH EPS & revenue forecast
EPS · NEXT QUARTER
$1.57
Range $1.40 – $1.73 · 6 analysts · +31% YoY
Next period, 6 analysts expect Meritage Corporation to earn $1.57 a share (range $1.40 – $1.73), versus $1.20 a year earlier. Full-year consensus is $5.00, growing to $6.10 the year after.
REVENUE · NEXT QUARTER
$1.6B
Range $1.5B – $1.6B · 6 analysts · +9% YoY
Revenue is expected to reach $1.6B (range $1.5B – $1.6B), +9.5% year-over-year. Full-year consensus is $5.4B, rising to $5.8B next year.
Top analysts covering Meritage Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MTH.
#1
Jade Rahmani
Keefe, Bruyette & Woods · Rank #12
Hold
$75.00+16.4% to target
Overall win rate
59%
+ Follow
#2
Jay McCanless
Wedbush · Rank #15
Hold
$90.00+39.7% to target
Overall win rate
64%
+ Follow
#3
John Lovallo
UBS
Buy
$88.00+36.6% to target
Coverage
—
+ Follow
#4
Michael Rehaut
JP Morgan
Hold
$58.00-10.0% to target
Coverage
—
+ Follow
#5
Rafe Jadrosich
B of A Securities
Hold
$72.00+11.8% to target
Coverage
—
+ Follow
MTH stock forecast FAQ
What is MTH's average 12-month price target?+
The 8 analysts with a live target average $78.25 for Meritage Corporation over the next 12 months, ranging from a $93.00 high to a $58.00 low.
Is MTH stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 9 analyst ratings, 4 are Buy or Strong Buy, 5 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for MTH?+
The Street-high target is $93.00 (Goldman Sachs), and the Street-low is $58.00 (JP Morgan). The average of all 8 active targets is $78.25.
How many Wall Street analysts cover MTH?+
9 analysts have an active rating on Meritage Corporation, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering MTH?+
Among analysts who currently cover MTH, Jade Rahmani of Keefe, Bruyette & Woods has the strongest overall Quantellect track record (Rank #12). Their current call is Hold with a $75.00 target.
What is Meritage Corporation's projected EPS for next quarter?+
The consensus estimate is $1.57 per share (range $1.40 – $1.73) across 6 analysts. Full-year EPS is projected at $5.00, rising to $6.10 the following year.
How much revenue is Meritage Corporation expected to report next quarter?+
Consensus revenue is $1.6B (range $1.5B – $1.6B). Full-year revenue is projected at $5.4B, growing to $5.8B next year.
Have analysts been upgrading or downgrading MTH lately?+
As of Sep, 4 of 9 firms rate MTH a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MTH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
